A pill has been found to almost double the survival time for advanced pancreatic cancer patients, with experts describing the trial as a game changer.

The drug, called daraxonrasib, appears to be a breakthrough in managing a disease that has the highest mortality rate of all major cancers.

Read more – BBC Health (1/6/26)